Reaction

Micturition Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,414 reports · 88 co-occurring drugs

As of the last recalculation, Micturition Disorder appears in 3,414 FAERS reports alongside 88 co-occurring drug terms. The strongest observed disproportionality signal is EPOETIN ALFA (PRR 12.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Epoetin Alfa	24	12.4	12.5
Fesoterodine Fumarate	20	11.3	11.3
Atomoxetine Hydrochloride	42	10.9	10.9
Relugolix	41	10.7	10.7
Rasagiline Mesylate	18	9.9	9.9
Amiodarone Hydrochloride	18	9.8	9.9
Canagliflozin	44	9.1	9.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled	27	7.8	7.8
Rosuvastatin Calcium	34	7.4	7.4
Doxepin	12	7.2	7.2
Torsemide	38	7.1	7.1
Hydroxyzine Hydrochloride	15	7.0	7.0
Hydroxyzine Hydrochloride Oral	15	7.0	7.0
Risedronate Sodium	35	6.9	6.9
Umeclidinium	10	6.8	6.8
Doxepin Hydrochloride	14	6.8	6.8
Umeclidinium Bromide And Vilanterol Trifenatate	18	6.6	6.6
Sitagliptin	73	6.3	6.3
Tolterodine Tartrate	9	6.1	6.1
Diroximel Fumarate	11	5.6	5.6
Ropinirole	14	5.6	5.6
Levodopa	11	5.6	5.6
Tolvaptan	13	5.5	5.5
Instalax Polyethylene Glycol 3350	11	5.4	5.4
Vibegron	7	5.3	5.3
Isosorbide Mononitrate	18	5.3	5.3
Polyethylene Glycol 400	11	5.3	5.3
Cabotegravir	7	5.3	5.3
Lubiprostone	8	5.2	5.2
Escitslopram	45	4.8	4.8
Vortioxetine	13	4.7	4.7
Piperacillin Sodium,Tazobactam Sodium	20	4.6	4.6
Oxybutynin	21	4.4	4.4
Amantadine	11	4.3	4.3
Teriflunomide	32	4.3	4.3
Piperacillin And Tazobactam	9	4.3	4.3
Dextrose	9	4.2	4.2
Dextrose Monohydrate	9	4.1	4.1
Granisetron Hydrochloride	7	4.1	4.1
Granisetron	7	4.1	4.1
Dofetilide	7	4.1	4.1
Metoprolol Tartrate Injection	121	4.0	4.0
Amlodipine Besylate And Valsartan	7	3.9	3.9
Finasteride	37	3.8	3.8
Epoprostenol	8	3.7	3.7
Sumatriptan Succinate	15	3.6	3.6
Mirabegron	22	3.5	3.5
Enzalutamide	32	3.3	3.3
Dapagliflozin	17	3.3	3.3
Ocrelizumab	33	3.3	3.3
Peginterferon Beta-1A	7	3.3	3.3
Teduglutide	7	3.2	3.2
Ziprasidone	9	3.1	3.1
Niraparib	11	3.0	3.0
Ziprasidone Mesylate	7	3.0	3.0
Dronedarone	5	3.0	3.0
Rotigotine	7	3.0	3.0
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	20	3.0	3.0
Budesonide, Glycopyrrolate, And Formoterol Fumarate	5	2.9	2.9
Dalfampridine	34	2.9	2.9
Dabigatran Etexilate	36	2.8	2.8
Selexipag	12	2.8	2.8
Brinzolamide	4	2.8	2.8
Desvenlafaxine Succinate	12	2.7	2.7
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	4	2.7	2.7
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	4	2.4	2.4
Loratadine And Pseudoephedrine Sulfate	3	2.3	2.3
Abiraterone	5	2.2	2.2
Fingolimod Hcl	30	2.1	2.1
Voclosporin	3	2.1	2.1
Apalutamide	4	2.1	2.1
Vismodegib	3	2.1	2.1
Avapritinib	4	2.0	2.0
Leuprolide Acetate	25	2.0	2.0
Suvorexant	4	1.9	1.9
Dimethyl Fumarate	36	1.8	1.8
Abiraterone Acetate	12	1.8	1.8
Emtricitabine And Tenofovir Disoproxil Fumarate	13	1.7	1.7
Pirfenidone	11	1.6	1.6
Ranitidine Hydrochloride	14	1.6	1.6
Exenatide	13	1.5	1.5
Abaloparatide	7	1.5	1.5
Sacubitril And Valsartan	26	1.4	1.4
Patiromer	3	1.3	1.3
Nirmatrelvir And Ritonavir	10	1.1	1.1
Pomalidomide	15	0.9	0.9
Valbenazine	3	0.7	0.7
Levonorgestrel	24	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.